Literature DB >> 22120186

Neuronal NOS inhibitor and conventional antidepressant drugs attenuate stress-induced fos expression in overlapping brain regions.

Michelle Silva1, Daniele C Aguiar, Cassiano R A Diniz, Francisco Silveira Guimarães, Sâmia R L Joca.   

Abstract

Recent evidence indicates that the administration of inhibitors of neuronal nitric oxide synthase (nNOS) induces antidepressant-like effects in animal models such as the forced swimming test (FST). However, the neural circuits involved in these effects are not yet known. Therefore, this study investigated the expression of Fos protein, a marker of neuronal activity, in the brain of rats submitted to FST and treated with the preferential nNOS inhibitor, 7-nitroindazole (7-NI), or with classical antidepressant drugs (Venlafaxine and Fluoxetine). Male Wistar rats were submitted to a forced swimming pretest (PT) and, immediately after, started receiving a sequence of three ip injections (0, 5, and 23 h after PT) of Fluoxetine (10 mg/kg), Venlafaxine (10 mg/kg), 7-NI (30 mg/kg) or respective vehicles. One hour after the last drug injection the animals were submitted to the test session, when immobility time was recorded. After the FST they were sacrificed and had their brains removed and processed for Fos immunohistochemistry. Independent group of non-stressed animals received the same drug treatments, or no treatment (naïve). 7-NI, Venlafaxine or Fluoxetine reduced immobility time in the FST, an antidepressant-like effect. None of the treatments induce significant changes in Fos expression per se. However, swimming stress induced significant increases in Fos expression in the following brain regions: medial prefrontal cortex, nucleus accumbens, locus coeruleus, raphe nuclei, striatum, hypothalamic nucleus, periaqueductal grey, amygdala, habenula, paraventricular nucleus of hypothalamus, and bed nucleus of stria terminalis. This effect was attenuated by 7-NI, Venlafaxine or Fluoxetine. These results show that 7-NI produces similar behavioral and neuronal activation effects to those of typical antidepressants, suggesting that these drugs share common neurobiological substrates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22120186     DOI: 10.1007/s10571-011-9775-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  72 in total

Review 1.  Stressor specificity of central neuroendocrine responses: implications for stress-related disorders.

Authors:  K Pacák; M Palkovits
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

2.  Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety.

Authors:  Patrik Muigg; Ulrike Hoelzl; Klara Palfrader; Inga Neumann; Alexandra Wigger; Rainer Landgraf; Nicolas Singewald
Journal:  Biol Psychiatry       Date:  2007-01-16       Impact factor: 13.382

3.  Acute restraint increases NADPH-diaphorase staining in distinct subregions of the rat dorsal raphe nucleus: implications for raphe serotonergic and nitrergic transmission.

Authors:  Chuma O Okere; Barry D Waterhouse
Journal:  Brain Res       Date:  2006-09-20       Impact factor: 3.252

4.  Behavioral and c-fos expression changes induced by nitric oxide donors microinjected into the dorsal periaqueductal gray.

Authors:  R W de Oliveira; E A Del Bel; F S Guimarães
Journal:  Brain Res Bull       Date:  2000-04       Impact factor: 4.077

5.  Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: role of 5HT 2A/C-receptors.

Authors:  Brian H Harvey; Renché Retief; Ané Korff; Gregers Wegener
Journal:  Metab Brain Dis       Date:  2006-07-22       Impact factor: 3.584

6.  A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.

Authors:  Valentina Gigliucci; Kathleen Niamh Buckley; John Nunan; Karen O'Shea; Andrew Harkin
Journal:  Pharmacol Biochem Behav       Date:  2009-11-26       Impact factor: 3.533

7.  A controlled trial of methylene blue in severe depressive illness.

Authors:  G J Naylor; A H Smith; P Connelly
Journal:  Biol Psychiatry       Date:  1987-05       Impact factor: 13.382

8.  c-Fos expression increase in NADPH-diaphorase positive neurons after exposure to a live cat.

Authors:  Vanessa Beijamini; Francisco Silveira Guimarães
Journal:  Behav Brain Res       Date:  2006-03-20       Impact factor: 3.332

9.  Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects.

Authors:  Sâmia Regiane Lourenço Joca; Francisco Silveira Guimarães
Journal:  Psychopharmacology (Berl)       Date:  2006-03-01       Impact factor: 4.530

Review 10.  Monoamine dysfunction and the pathophysiology and treatment of depression.

Authors:  D S Charney
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

View more
  11 in total

1.  Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats.

Authors:  Ekaterina V Medvedeva; Veronika G Dmitrieva; Svetlana A Limborska; Nikolay F Myasoedov; Lyudmila V Dergunova
Journal:  Mol Genet Genomics       Date:  2017-03-02       Impact factor: 3.291

2.  Antidepressant Like Effect of Ascorbic Acid in Mice: Possible Involvement of NO-sGC-cGMP Signaling.

Authors:  Sushma Maratha; Vijay Sharma; Vaibhav Walia
Journal:  Neurochem Res       Date:  2021-11-25       Impact factor: 3.996

3.  Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression.

Authors:  Anthony J Hannan; Thibault Renoir; Volkan Uzungil; Harvey Tran; Connor Aitken; Carey Wilson; Carlos M Opazo; Shanshan Li; Jennyfer M Payet; Celeste H Mawal; Ashley I Bush; Matthew W Hale
Journal:  Neurotherapeutics       Date:  2022-07-21       Impact factor: 6.088

4.  Functional integrity of the habenula is necessary for social play behaviour in rats.

Authors:  Linda W M van Kerkhof; Ruth Damsteegt; Viviana Trezza; Pieter Voorn; Louk J M J Vanderschuren
Journal:  Eur J Neurosci       Date:  2013-09-16       Impact factor: 3.386

5.  Dual role of nitrergic neurotransmission in the bed nucleus of the stria terminalis in controlling cardiovascular responses to emotional stress in rats.

Authors:  Lucas Barretto-de-Souza; Mariane B Adami; Ricardo Benini; Carlos C Crestani
Journal:  Br J Pharmacol       Date:  2018-08-17       Impact factor: 8.739

6.  Neuronal nitric oxide synthase (NOS1) polymorphisms interact with financial hardship to affect depression risk.

Authors:  Jane E Sarginson; J F William Deakin; Ian M Anderson; Darragh Downey; Emma Thomas; Rebecca Elliott; Gabriella Juhasz
Journal:  Neuropsychopharmacology       Date:  2014-06-11       Impact factor: 7.853

7.  Pattern of c-Fos expression induced by tail suspension test in the mouse brain.

Authors:  Kentaro Hiraoka; Keisuke Motomura; Satoru Yanagida; Ayako Ohashi; Nozomi Ishisaka-Furuno; Shigenobu Kanba
Journal:  Heliyon       Date:  2017-06-02

8.  Changes in c-Fos Expression in the Forced Swimming Test: Common and Distinct Modulation in Rat Brain by Desipramine and Citalopram.

Authors:  Sun Hye Choi; Sung Chung; Jin Hee Cho; Yun Ha Cho; Jin Wook Kim; Jeong Min Kim; Hee Jeong Kim; Hyun Ju Kim; Kyung Ho Shin
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

9.  Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat.

Authors:  Eoin Sherwin; Aifric Lennon; Andrew Harkin
Journal:  Int J Neuropsychopharmacol       Date:  2017-10-01       Impact factor: 5.176

Review 10.  Neuronal nitric oxide synthase and affective disorders.

Authors:  Qi-Gang Zhou; Xian-Hui Zhu; Ashley D Nemes; Dong-Ya Zhu
Journal:  IBRO Rep       Date:  2018-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.